Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.9M Sell
3,549,006
-2,444,216
-41% -$22.4M 0.04% 324
2026
Q1
$55.7M Buy
+5,993,222
New +$59M 0.07% 208
2025
Q3
$29M Buy
+5,073,316
New +$27.1M 0.16% 98

Other funds holding NEOG

CIBC Bancorp USA's NEOG Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Neogen (NEOG) stake by 41% in Q2 2026, selling an estimated $22.4M and leaving 3,549,006 shares worth $31.9M. The position accounts for 0.04% of the portfolio, ranked #324.

CIBC Bancorp USA first reported a position in NEOG in Q3 2025 and has held it in 3 quarters since. The position peaked at $55.7M in Q1 2026. 295 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • CIBC Bancorp USA held 3,549,006 shares of Neogen worth $31.9M as of Q2 2026.
  • CIBC Bancorp USA sold 2,444,216 Neogen shares in Q2 2026, an estimated $22.4M.
  • Neogen made up 0.04% of CIBC Bancorp USA's portfolio in Q2 2026, its #324 holding.
  • CIBC Bancorp USA first reported a position in Neogen in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Neogen position peaked at $55.7M in Q1 2026.
  • 295 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.